<SEC-DOCUMENT>0001683168-19-003516-index.html : 20191108
<SEC-HEADER>0001683168-19-003516.hdr.sgml : 20191108
<ACCEPTANCE-DATETIME>20191108173021
ACCESSION NUMBER:		0001683168-19-003516
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191107
FILED AS OF DATE:		20191108
DATE AS OF CHANGE:		20191108

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gumulka Jerzy
		CENTRAL INDEX KEY:			0001793252

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39126
		FILM NUMBER:		191205166

	MAIL ADDRESS:	
		STREET 1:		C/O CNS PHARMACEUTICALS, INC.
		STREET 2:		2100 WEST LOOP SOUTH STE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CNS Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001729427
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				822318545
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
		BUSINESS PHONE:		1-800-946-9185 X701

	MAIL ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>gumulka_f3-poa.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
Document 2 - file: gumulka_f3-poa.htm

</DOCUMENT>
</SEC-DOCUMENT>